Dong X - Search Results

1

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations.

Wang J, Zhang B, Peng L, Liu X, Sun J, Su C, Wang H, Zhao Z, Si L, Duan J, Zhang H, Li M, Zhu B, Zhang L, Li J, Guo J, Luo R, Qiu W, Ye D, Chu Q, Cui J, Dong X, Fan Y, Gao Q, Guo Y, He Z, Li W, Lin G, Liu L, Liu Y, Qin H, Ren S, Ren X, Wang Y, Xue J, Yang Y, Yang Z, Yue L, Zhan X, Zhang J, Ma J, Qin S, Wang B. Wang J, et al. Among authors: dong x. Ther Adv Med Oncol. 2023 Jul 16;15:17588359231187205. doi: 10.1177/17588359231187205. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37484525 Free PMC article. Review.

2

Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.

Zhang JT, Li Y, Yan LX, Zhu ZF, Dong XR, Chu Q, Wu L, Zhang HM, Xu CW, Lin G, Yu ZY, Hu J, Zhu B, Wang HJ, Yang F, Song ZB, Han ZB, Li MX, Lin J, Wu YL, Wang JL, Zhong WZ. Zhang JT, et al. Lung Cancer. 2020 Jan;139:118-123. doi: 10.1016/j.lungcan.2019.11.004. Epub 2019 Nov 11. Lung Cancer. 2020. PMID: 31775086 Free article.

3

Conformational Landscapes of HER2 Exon 20 Insertions Explain Their Sensitivity to Kinase Inhibitors in Lung Adenocarcinoma.

Zhao S, Fang W, Pan H, Yang Y, Liang Y, Yang L, Dong X, Zhan J, Wang K, Zhang L. Zhao S, et al. Among authors: dong x. J Thorac Oncol. 2020 Jun;15(6):962-972. doi: 10.1016/j.jtho.2020.01.020. Epub 2020 Feb 7. J Thorac Oncol. 2020. PMID: 32036069 Free article.

4

Mutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in HER2-Mutant Lung Adenocarcinoma.

Fang W, Zhao S, Liang Y, Yang Y, Yang L, Dong X, Zhang L, Tang Y, Wang S, Yang Y, Ma X, Wang M, Wang W, Zhao S, Wang K, Gao S, Zhang L. Fang W, et al. Among authors: dong x. Oncologist. 2020 Mar;25(3):e545-e554. doi: 10.1634/theoncologist.2019-0547. Epub 2019 Nov 20. Oncologist. 2020. PMID: 32162827 Free PMC article.

5

Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study.

Lu C, Dong XR, Zhao J, Zhang XC, Chen HJ, Zhou Q, Tu HY, Ai XH, Chen XF, An GL, Bai J, Shan JL, Wang YN, Yang SY, Liu X, Zhuang W, Wu HT, Zhu B, Xia XF, Chen RR, Gu DJ, Xu HM, Wu YL, Yang JJ. Lu C, et al. Among authors: dong xr. J Hematol Oncol. 2020 Apr 15;13(1):37. doi: 10.1186/s13045-020-00866-6. J Hematol Oncol. 2020. PMID: 32295619 Free PMC article.

6

The effect of combining Endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer.

Peng L, Wang Y, Fei S, Wei C, Tong F, Wu G, Ma H, Dong X. Peng L, et al. Among authors: dong x. Transl Lung Cancer Res. 2020 Jun;9(3):745-760. doi: 10.21037/tlcr-20-500. Transl Lung Cancer Res. 2020. PMID: 32676336 Free PMC article.

7

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma.

Guo LH, Zhang MF, Zhang HL, Zhou JY, Cai XH, Long Y, Guo QS, Yang N, Zhao J, Xie ZH, Jiang B, Zhu Y, Fan Y, Xie CY, Hu Y, Yao Y, Jia J, Li XL, Cui JW, Sui XZ, Lin W, Cheng Y, Wang HJ, Wang CL, Zhao MF, Qiao GB, Peng LJ, Yang L, Chen GY, Cai KC, Xu XH, Zhang LM, Feng GS, Zhou JM, Wu GW, Dong XR, Wang LF, Zhang HM, Gao YJ, Jiang QY, Cang SD, Yang ZX, Song X, Liu XQ, Zhu B, Chen FX, Hu CH, Chen X, Wu YL, Zhou Q. Guo LH, et al. Among authors: dong xr. Front Oncol. 2020 Sep 15;10:1568. doi: 10.3389/fonc.2020.01568. eCollection 2020. Front Oncol. 2020. PMID: 33042801 Free PMC article.

8

E2F1-mediated repression of WNT5A expression promotes brain metastasis dependent on the ERK1/2 pathway in EGFR-mutant non-small cell lung cancer.

Li H, Tong F, Meng R, Peng L, Wang J, Zhang R, Dong X. Li H, et al. Among authors: dong x. Cell Mol Life Sci. 2021 Mar;78(6):2877-2891. doi: 10.1007/s00018-020-03678-6. Epub 2020 Oct 19. Cell Mol Life Sci. 2021. PMID: 33078208

9

Association between recent oncologic treatment and mortality among patients with carcinoma who are hospitalized with COVID-19: A multicenter study.

Song K, Gong H, Xu B, Dong X, Li L, Hu W, Wang Q, Xie Z, Rao Z, Luo Z, Chu Q, Li F, Wang J. Song K, et al. Among authors: dong x. Cancer. 2021 Feb 1;127(3):437-448. doi: 10.1002/cncr.33240. Epub 2020 Nov 2. Cancer. 2021. PMID: 33136293 Free article.

10

Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling pathway.

Tong F, Xiong CJ, Wei CH, Wang Y, Liang ZW, Lu H, Pan HJ, Dong JH, Zheng XF, Wu G, Dong XR. Tong F, et al. Ther Adv Med Oncol. 2020 Oct 29;12:1758835920965853. doi: 10.1177/1758835920965853. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33193827 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,664 results

Search Page